Ingenza Overview
- Year Founded
-
2002
- Status
-
Private
- Employees
-
48
- Latest Deal Type
-
Later Stage VC
- Investors
-
6
Ingenza General Information
Description
Operator of a biotechnology company intended to generate innovative biobased systems for a diverse range of customer problems. The company's services provide efficient, scalable bioprocesses for the manufacture of chemicals, biologics, pharmaceuticals, and biofuels, from sustainable sources, and have assembled integrated teams of scientists bringing together expertise across synthetic chemistry, informatics, molecular genetics, biochemistry, and fermentation scale-up, enabling clients to shorten the bioengineering design and test cycle and successfully construct bioprocesses.
Contact Information
Website
www.ingenza.comCorporate Office
- Moubray Building Edinburgh Technopole
- Milton Bridge
- Penicuik EH26 0GB
- Scotland, United Kingdom
Corporate Office
- Moubray Building Edinburgh Technopole
- Milton Bridge
- Penicuik EH26 0GB
- Scotland, United Kingdom
Ingenza Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Later Stage VC | 01-Jan-2025 | Completed | Generating Revenue | |||
| 11. Grant | 25-Apr-2024 | Completed | Generating Revenue | |||
| 10. Grant | 01-Oct-2022 | Completed | Generating Revenue | |||
| 9. Grant | 01-Mar-2021 | Completed | Generating Revenue | |||
| 8. Grant | 01-May-2020 | Completed | Generating Revenue | |||
| 7. Grant | 01-Jul-2019 | Completed | Generating Revenue | |||
| 6. Grant | 04-Jul-2017 | Completed | Generating Revenue | |||
| 5. Grant | 16-Aug-2016 | Completed | Generating Revenue | |||
| 4. Grant | 15-Feb-2016 | $1.44M | Completed | Generating Revenue | ||
| 3. Grant | 06-Apr-2006 | $174K | Completed | Generating Revenue |
Ingenza Comparisons
Industry
Financing
Details
Ingenza Competitors (29)
One of Ingenza’s 29 competitors is Cellecta, a Private Debt Financed company based in Mountain View, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cellecta | Private Debt Financed | Mountain View, CA | ||||
| Molecular Devices | Corporate Backed or Acquired | San Jose, CA | ||||
| Arzeda | Venture Capital-Backed | Seattle, WA | ||||
| Codexis | Formerly VC-backed | Redwood City, CA | ||||
| Spiber | Venture Capital-Backed | Stockholm, Sweden |
Ingenza Patents
Ingenza Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4294438-A1 | Endotoxin-free production of recombinant subunit vaccine components | Pending | 18-Feb-2021 | ||
| GB-202314088-D0 | Endotoxin-free production of recombinant subunit vaccine components | Pending | 18-Feb-2021 | ||
| GB-2619239-A | Endotoxin-free production of recombinant subunit vaccine components | Pending | 18-Feb-2021 | ||
| US-20220282264-A1 | Endotoxin-free production of recombinant subunit vaccine components | Inactive | 18-Feb-2021 | ||
| WO-2022175871-A1 | Endotoxin-free production of recombinant subunit vaccine components | Inactive | 18-Feb-2021 | C12N15/75 |
Ingenza Signals
Ingenza Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| The FSE Group | Venture Capital | Minority | ||
| Horizon 2020 | Government | |||
| Innovate UK | Government | |||
| Scottish Enterprise | Growth/Expansion | |||
| The University of Edinburgh | University |
Ingenza Investments (6)
Ingenza’s most recent deal was a Later Stage VC with ProFactor Pharma for . The deal was made on 30-Sep-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ProFactor Pharma | 30-Sep-2022 | Later Stage VC | Drug Discovery | ||
| Amprologix | 20-Sep-2018 | Corporate | Drug Discovery | ||
| ProFactor Pharma | 16-Sep-2016 | Later Stage VC | Drug Discovery | ||
| ProFactor Pharma | 31-Mar-2015 | Later Stage VC | Drug Discovery | ||
| ProFactor Pharma | 20-Aug-2013 | Seed Round | Drug Discovery |
Ingenza FAQs
-
When was Ingenza founded?
Ingenza was founded in 2002.
-
Where is Ingenza headquartered?
Ingenza is headquartered in Penicuik, United Kingdom.
-
What is the size of Ingenza?
Ingenza has 48 total employees.
-
What industry is Ingenza in?
Ingenza’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Ingenza a private or public company?
Ingenza is a Private company.
-
What is Ingenza’s current revenue?
The current revenue for Ingenza is .
-
Who are Ingenza’s investors?
The FSE Group, Horizon 2020, Innovate UK, Scottish Enterprise, and The University of Edinburgh are 5 of 6 investors who have invested in Ingenza.
-
Who are Ingenza’s competitors?
Cellecta, Molecular Devices, Arzeda, Codexis, and Spiber are some of the 29 competitors of Ingenza.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process